These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 33959962)
1. Evaluation of plasma and urinary levels of vascular endothelial growth factor and matrix metalloproteinase-9 in patients with infantile hemangioma. Rotter A; Lima XT; Oliveira ZNP Int J Dermatol; 2021 Oct; 60(10):1263-1269. PubMed ID: 33959962 [TBL] [Abstract][Full Text] [Related]
2. Importance of Determining Vascular Endothelial Growth Factor Serum Levels in Children with Infantile Hemangioma. Rešić A; Benco Kordić N; Obuljen J; Bašković M Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003963 [No Abstract] [Full Text] [Related]
3. Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma. Makkeyah SM; Elseedawy ME; Abdel-Kader HM; Mokhtar GM; Ragab IA Pediatr Hematol Oncol; 2022 Apr; 39(3):215-224. PubMed ID: 34477031 [TBL] [Abstract][Full Text] [Related]
4. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes. Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699 [TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas? Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692 [TBL] [Abstract][Full Text] [Related]
6. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol. Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma. Aydin Köker S; Kömüroğlu AU; Köksoy AY; Şiraz ÜG; Tekin E; Köker A Arch Pediatr; 2021 May; 28(4):296-300. PubMed ID: 33715934 [TBL] [Abstract][Full Text] [Related]
8. Expression and correlation of MMP-9, VEGF, and p16 in infantile hemangioma. Yin RR; Hao D; Chen P Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4806-4811. PubMed ID: 30070315 [TBL] [Abstract][Full Text] [Related]
9. [Effects of oral propranolol on urine bFGF, MMP-2, MMP-9 expression in children with proliferative infantile hemangioma]. Yuan WL; Wang XK Shanghai Kou Qiang Yi Xue; 2022 Aug; 31(4):400-405. PubMed ID: 36710554 [TBL] [Abstract][Full Text] [Related]
10. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol. Rotter A; de Oliveira ZNP J Dtsch Dermatol Ges; 2017 Dec; 15(12):1185-1190. PubMed ID: 29193649 [TBL] [Abstract][Full Text] [Related]
11. Propranolol for infantile hemangioma: Effect on plasma vascular endothelial growth factor. Ozeki M; Nozawa A; Hori T; Kanda K; Kimura T; Kawamoto N; Fukao T Pediatr Int; 2016 Nov; 58(11):1130-1135. PubMed ID: 26991797 [TBL] [Abstract][Full Text] [Related]
12. Single-nucleotide polymorphisms of VEGF-A and VEGFR-2 genes and risk of infantile hemangioma. Oszajca K; Szemraj J; Wyrzykowski D; Chrzanowska B; Salamon A; Przewratil P Int J Dermatol; 2018 Oct; 57(10):1201-1207. PubMed ID: 29984822 [TBL] [Abstract][Full Text] [Related]
13. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer. Lin SY; Wang YY; Sheu WH Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636 [TBL] [Abstract][Full Text] [Related]
14. A study of serum vascular endothelial growth factor in infantile hemangiomas. Paria S; Mendiratta V; Chander R; Jain A; Mittal S Indian J Dermatol Venereol Leprol; 2019; 85(1):65-68. PubMed ID: 29469063 [TBL] [Abstract][Full Text] [Related]
15. Tissue and serum mRNA profile of MMPs-2/9 as a potential novel biomarker for the most individual approach in infantile hemangiomas and cancer disease. Taran K; Wnęk A; Kobos J; Andrzejewska E; Przewratil P Immunobiology; 2017 Nov; 222(11):1035-1042. PubMed ID: 28601470 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of VEGF and bFGF in infantile hemangiomas treated with propranolol. Şen HS; Yalçın B; Canpınar H; Ocak S; Akyüz C Turk J Pediatr; 2020; 62(6):979-985. PubMed ID: 33372436 [TBL] [Abstract][Full Text] [Related]
17. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy. Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679 [TBL] [Abstract][Full Text] [Related]
18. Propranolol inhibits proliferation and invasion of hemangioma-derived endothelial cells by suppressing the DLL4/Notch1/Akt pathway. Sun B; Dong C; Lei H; Gong Y; Li M; Zhang Y; Zhang H; Sun L Chem Biol Interact; 2018 Oct; 294():28-33. PubMed ID: 30130526 [TBL] [Abstract][Full Text] [Related]
19. One Possible Mechanism of Pulsed Dye Laser Treatment on Infantile Hemangioma: Induction of Endothelial Apoptosis and Serum vascular endothelial growth factor (VEGF) Level Changes. Cao Y; Wang F; Jia Q; Xu R; Dang W; Chen Q; Lin L; Wang Y J Lasers Med Sci; 2014; 5(2):75-81. PubMed ID: 25653803 [TBL] [Abstract][Full Text] [Related]
20. [Effect of propranolol gel on plasma VEGF, bFGF and MMP-9 in proliferating infantile hemangiomas of superficial type]. Yujuan T; Shaoquan C; Zaizhong Z; Shuming C; Guoliang H; Lie W Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Jul; 31(4):268-73. PubMed ID: 26665926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]